SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-182326
Filing Date
2020-06-29
Accepted
2020-06-29 16:06:31
Documents
14
Period of Report
2020-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d23206d8k.htm   iXBRL 8-K 49020
2 EX-99.1 d23206dex991.htm EX-99.1 58076
3 EX-99.2 d23206dex992.htm EX-99.2 16500
  Complete submission text file 0001193125-20-182326.txt   267453

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acad-20200623.xsd EX-101.SCH 3082
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20200623_lab.xml EX-101.LAB 18139
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20200623_pre.xml EX-101.PRE 11416
7 EXTRACTED XBRL INSTANCE DOCUMENT d23206d8k_htm.xml XML 3417
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 20997542
SIC: 2834 Pharmaceutical Preparations